TempoPay Rx Launches to Help Employees Access and Afford Prescription Drugs

Milwaukee, WI – April 29, 2025

TempoPay announced the availability of TempoPay Rx, a financing solution designed to address the growing trend in prescription drug non-adherence nationally.

“We are excited to bring TempoPay Rx to the market and help create simpler and more affordable access to prescription medications for our clients,” said Tom Policelli, CEO, PayMedix. “We have seen how decreasing financial barriers to medical care has improved health outcomes for members and financial results for our employer clients. Expanding this to include pharmacy costs is the next logical step to help consumers get the care they need when they need it."

With prescription drug prices rising at more than twice the rate of inflation, access and affordability for the nearly two-thirds (61%) of Americans who take prescription medications have become a serious concern. More than half (55%) of Americans report being worried about affording their prescription drug costs, and nearly one-third (31%) have avoided taking medications as prescribed due to cost.

TempoPay Rx is a card-based financing solution that provides enrolled employees access to interest-free financing for prescription medications. Employees of participating employers can receive the benefit with no credit checks or income requirements. The program offers interest and fee-free financing on a revolving basis, with flexible repayments made via bank account or convenient payroll deductions.

PayMedix has been providing interest-free financing for in-network medical care for over 15 years. A recently completed study demonstrates the long-term benefits of its innovative payments solution on 45,000 active members in Wisconsin. The study found that not only was inpatient hospital care of PayMedix members 8% lower than national averages, but employer medical trend increases were nearly 40% lower than the national average.

“Making prescription medications more accessible by lowering the financing barriers ultimately brings the cost of healthcare down,” said Brian Marsella, President, PayMedix. “It’s a fact that medication non-adherence leads to worsening health, increased emergency room visits and hospital admissions, driving costs higher. Our clients have experienced enormous value from our medical care financing and have asked for expanded support for prescription medications."